Robert Williams

Dr. Robert Williams

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 January 2020 in Organic Process Research & Development
Verified
Journal Article
Closed access
PDPavel A. Dub
Pavel A. Dub
RBRami J. Batrice
Rami J. Batrice
JGJohn C. Gordon
John C. Gordon
BSBrian L. Scott
Brian L. Scott
YMYury Minko
Yury Minko
RWRobert Williams
Robert Williams

19 September 2025 in Protein Science
Verified
Journal Article
Open access
LHLi‐Wei Hung
Li‐Wei Hung
KSKarissa Sanbonmatsu
Karissa Sanbonmatsu
RWRobert Williams
Robert Williams
JCJulian C.‐H. Chen
Julian C.‐H. Chen
Acetylcholinesterase (AChE) is an enzyme that hydrolyzes the neurotransmitter acetylcholine (ACh), removing it from the synaptic cleft after the transmission of an electrical signal, making it an essential component of chemical neurotransmission. AChE is a serine hydrolase, containing a catalytic triad of Ser/His/Glu. AChE is a prime target for pharmaceuticals treating a variety of neurological disorders. It is also the target of synthetic organophosphorus (OP) compounds that have been used as pesticides and chemical warfare agents. OP compounds contain a potent leaving group, such as fluorine, and act by forming a covalent adduct with the catalytic serine of the AChE active site. A wealth of structural information is available for AChE, including over 300 structures, including a subset of structures in complex with drugs as well as OP compounds. This review will highlight the interactions between OP compounds and AChE from a structural and computational perspective, with a discussion of access to the active site, as well as side reactions that lead to dealkylation of the OP‐catalytic serine adduct, a process known as aging. We conclude that while the majority of the conformational changes needed to accommodate the OP compounds are localized to the acyl loop in the crystal structures, molecular dynamics simulations highlight the potential for a far more dynamic enzyme.

31 May 2020 in Applied Sciences
Verified
Journal Article
Open access
PDF file
DKDerrick Kaseman
Derrick Kaseman
MJMichael Janicke
Michael Janicke
RFRachel K. Frankle
Rachel K. Frankle
TNTammie Nelson
Tammie Nelson
GAGary Angles-Tamayo
Gary Angles-Tamayo
RWRobert Williams
Robert Williams
Chemical analysis via nuclear magnetic resonance (NMR) spectroscopy using permanent magnets, rather than superconducting magnets, is a rapidly developing field. Performing the NMR measurement in the strong heteronuclear J-coupling regime has shown considerable promise for the chemical analysis of small molecules. Typically, the condition for the strong heteronuclear J-coupling regime is satisfied at µT magnetic field strengths and enables high resolution J-coupled spectra (JCS) to be acquired. However, the JCS response to systematic chemical structural changes has largely not been investigated. In this report, we investigate the JCS of C6H6−xFx (x = 0, 1, 2, …, 6) fluorobenzene compounds via simultaneous excitation and detection of 19F and 1H at 51.5 µT. The results demonstrate that JCS are quantitative, and the common NMR observables, including Larmor frequency, heteronuclear and homonuclear J-couplings, relative signs of the J-coupling, chemical shift, and relaxation, are all measurable and are differentiable between molecules at low magnetic fields. The results, corroborated by ab initio calculations, provide new insights into the impact of chemical structure and their corresponding spin systems on JCS. In several instances, the JCS provided more chemical information than traditional high field NMR, demonstrating that JCS can be used for robust chemical analysis.

1 December 2020 in Solid State Nuclear Magnetic Resonance
Verified
Journal Article
Closed access
MMMichael W. Malone
Michael W. Malone
MEMichelle Espy
Michelle Espy
SHSun He
Sun He
MJMichael T. Janicke
Michael T. Janicke
RWRobert Williams
Robert Williams

1 April 1991 in Endocrinology
Verified
Journal Article
Closed access
PDF file
DDDouglas R. Danforth
Douglas R. Danforth
RWRobert Williams
Robert Williams
KGKeith Gordon
Keith Gordon
JLJuan A. Leal
Juan A. Leal
GHGary D. Hodgen
Gary D. Hodgen
Previous data from this laboratory revealed a rapid and unexpectedly long inhibition of pituitary gonadotropin secretion in ovariectomized monkeys after a single high dose injection of the GnRH antagonist antide. This extended action of antide may correlate with an extended presence of antide in the peripheral circulation. We have reported on use of a RRA for antide in serum; however, during such a prolonged presence in the body, the possibility of catabolic loss of biological activity remained to be analyzed. In the present study, we have developed an in vitro pituitary cell bioassay for antide to investigate the pharmacokinetics and possible mechanism (s) contributory to its long action. Dispersed anterior pituitary cells from adult female rats were plated (48 h; 5 × 10s cells/well), washed, and incubated with 0.024–6 ng antide for 24 h. Media were removed, and cells were washed twice and then incubated with GnRH (1 × 10-8 M) plus antide standards or serum samples for 4 h. Before antide injection into long term ovariectomized monkeys, peripheral GnRH antagonist levels were undetectable. One day after a single injection (3.0 mg/kg, sc, in 50% propylene glycol-water), the level of antide was 31 ± 13 ng/ml (n = 3). Thereafter, antide levels declined slowly and were still detectable (<1.4 ng/ml) in two of three monkeys 31 days after injection. After iv administration (3.0 mg/kg; n = 2), peripheral antide levels followed a similar pharmacokinetic profile and declined slowly. Detectable antide concentrations were still present 36 days after single iv injection in both monkeys. The circulating half-lives of antide were 1.7 and 14.5 days for the first and second phases, respectively. Peripheral LH levels were suppressed to the limits of detectability within 1 day and slowly recovered to pretreatment levels within 30 ± 5 days after sc or iv antide treatment. The ratio of bioactive antide to antide levels measured by RRA was similar throughout the study (x = 1.24 ± 0.09; range, 0.40–2.22), although there was a trend toward an increased B/R ratio at the end of the study. In summary, we have developed an in vitro bioassay using cultured rat pituitary cells to measure biologically active antide concentrations in peripheral circulation after sc and iv treatments. The prolonged action of antide on pituitary gonadotropin secretion in vivo is apparently due to the continued presence of biologically active antide in circulation after a single injection. The sustained presence of antide in peripheral blood probably reflects its entry into circulation from a peripheral depot site(s), whether given sc or iv, as well as its long t½ for clearance. The pharmacokinetic curves for antide in serum were similar in bioassay and RRA during an extended but reversible interval of LH suppression. (Endocrinology128: 2041–2044,1991)

8 November 2021 in Analytical Chemistry
Verified
Journal Article
Closed access
DKDerrick Kaseman
Derrick Kaseman
MMMichael W. Malone
Michael W. Malone
ATAaron Tondreau
Aaron Tondreau
MEMichelle A. Espy
Michelle A. Espy
RWRobert Williams
Robert Williams